Global Liver Diseases Therapeutics Drugs Sales Market Report 2017

世界の肝臓病治療薬市場:販売動向2017

◆タイトル:Global Liver Diseases Therapeutics Drugs Sales Market Report 2017
◆商品コード:QYR70323058
◆調査・発行会社:QYResearch
◆発行日:2017年1月25日
◆ページ数:118
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥864,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、肝臓病治療薬の世界市場について調査・分析し、肝臓病治療薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、肝臓病治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・肝臓病治療薬市場概要
・肝臓病治療薬のメーカー別販売量・メーカー別シェア
・肝臓病治療薬の世界市場:種類別販売量・市場シェア
・肝臓病治療薬の世界市場:用途別販売量・市場シェア
・肝臓病治療薬の世界市場:地域別販売量・市場シェア
・肝臓病治療薬のアメリカ市場規模
・肝臓病治療薬の中国市場規模
・肝臓病治療薬のヨーロッパ市場規模
・肝臓病治療薬の日本市場規模
・肝臓病治療薬の東南アジア市場規模
・肝臓病治療薬のインド市場規模
・肝臓病治療薬のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・肝臓病治療薬のコスト分析・価格動向
・肝臓病治療薬の産業チェーン(サプライチェーン分析)
・肝臓病治療薬のマーケティング戦略・販売チャネル、流通業者
・肝臓病治療薬市場への影響要因分析
・肝臓病治療薬の世界市場予測
・肝臓病治療薬のアメリカ市場予測
・肝臓病治療薬の中国市場予測
・肝臓病治療薬のヨーロッパ市場予測
・肝臓病治療薬の日本市場予測
・肝臓病治療薬の東南アジア市場予測
・肝臓病治療薬のインド市場予測
・肝臓病治療薬の種類別世界市場予測
・肝臓病治療薬の用途別世界市場予測
...

Notes:Sales, means the sales volume of Liver Diseases Therapeutics Drugs
Revenue, means the sales value of Liver Diseases Therapeutics Drugs

This report studies sales (consumption) of Liver Diseases Therapeutics Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Achillion Pharmaceuticals,
AbbVie
Angion Biomedica
Bayer
LG Life Sciences
Phenex Pharmaceuticals
ProMetic Life Sciences
Raptor Pharmaceuticals
Shenzhen Kangtai Biological Products
Verva Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Liver Diseases Therapeutics Drugs in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Oral
Injection
Split by applications, this report focuses on sales, market share and growth rate of Liver Diseases Therapeutics Drugs in each application, can be divided into
Hospital
Clinic

【レポートの目次】

Table of Contents

Global Liver Diseases Therapeutics Drugs Sales Market Report 2017
1 Liver Diseases Therapeutics Drugs Overview
1.1 Product Overview and Scope of Liver Diseases Therapeutics Drugs
1.2 Classification of Liver Diseases Therapeutics Drugs
1.2.1 Oral
1.2.2 Injection
1.3 Application of Liver Diseases Therapeutics Drugs
1.3.1 Hospital
1.3.2 Clinic
1.4 Liver Diseases Therapeutics Drugs Market by Regions
1.4.1 United States Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Liver Diseases Therapeutics Drugs (2011-2021)
1.5.1 Global Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2021)
1.5.2 Global Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2021)

2 Global Liver Diseases Therapeutics Drugs Competition by Manufacturers, Type and Application
2.1 Global Liver Diseases Therapeutics Drugs Market Competition by Manufacturers
2.1.1 Global Liver Diseases Therapeutics Drugs Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Liver Diseases Therapeutics Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Liver Diseases Therapeutics Drugs (Volume and Value) by Type
2.2.1 Global Liver Diseases Therapeutics Drugs Sales and Market Share by Type (2011-2016)
2.2.2 Global Liver Diseases Therapeutics Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Liver Diseases Therapeutics Drugs (Volume and Value) by Regions
2.3.1 Global Liver Diseases Therapeutics Drugs Sales and Market Share by Regions (2011-2016)
2.3.2 Global Liver Diseases Therapeutics Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Liver Diseases Therapeutics Drugs (Volume) by Application

3 United States Liver Diseases Therapeutics Drugs (Volume, Value and Sales Price)
3.1 United States Liver Diseases Therapeutics Drugs Sales and Value (2011-2016)
3.1.1 United States Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
3.1.2 United States Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
3.1.3 United States Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
3.2 United States Liver Diseases Therapeutics Drugs Sales and Market Share by Manufacturers
3.3 United States Liver Diseases Therapeutics Drugs Sales and Market Share by Type
3.4 United States Liver Diseases Therapeutics Drugs Sales and Market Share by Application

4 China Liver Diseases Therapeutics Drugs (Volume, Value and Sales Price)
4.1 China Liver Diseases Therapeutics Drugs Sales and Value (2011-2016)
4.1.1 China Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
4.1.2 China Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
4.1.3 China Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
4.2 China Liver Diseases Therapeutics Drugs Sales and Market Share by Manufacturers
4.3 China Liver Diseases Therapeutics Drugs Sales and Market Share by Type
4.4 China Liver Diseases Therapeutics Drugs Sales and Market Share by Application

5 Europe Liver Diseases Therapeutics Drugs (Volume, Value and Sales Price)
5.1 Europe Liver Diseases Therapeutics Drugs Sales and Value (2011-2016)
5.1.1 Europe Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
5.1.2 Europe Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
5.1.3 Europe Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
5.2 Europe Liver Diseases Therapeutics Drugs Sales and Market Share by Manufacturers
5.3 Europe Liver Diseases Therapeutics Drugs Sales and Market Share by Type
5.4 Europe Liver Diseases Therapeutics Drugs Sales and Market Share by Application

6 Japan Liver Diseases Therapeutics Drugs (Volume, Value and Sales Price)
6.1 Japan Liver Diseases Therapeutics Drugs Sales and Value (2011-2016)
6.1.1 Japan Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
6.1.2 Japan Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
6.1.3 Japan Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
6.2 Japan Liver Diseases Therapeutics Drugs Sales and Market Share by Manufacturers
6.3 Japan Liver Diseases Therapeutics Drugs Sales and Market Share by Type
6.4 Japan Liver Diseases Therapeutics Drugs Sales and Market Share by Application
7 Southeast Asia Liver Diseases Therapeutics Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Liver Diseases Therapeutics Drugs Sales and Value (2011-2016)
7.1.1 Southeast Asia Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
7.1.2 Southeast Asia Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
7.1.3 Southeast Asia Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
7.2 Southeast Asia Liver Diseases Therapeutics Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Liver Diseases Therapeutics Drugs Sales and Market Share by Type
7.4 Southeast Asia Liver Diseases Therapeutics Drugs Sales and Market Share by Application
8 India Liver Diseases Therapeutics Drugs (Volume, Value and Sales Price)
8.1 India Liver Diseases Therapeutics Drugs Sales and Value (2011-2016)
8.1.1 India Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
8.1.2 India Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
8.1.3 India Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
8.2 India Liver Diseases Therapeutics Drugs Sales and Market Share by Manufacturers
8.3 India Liver Diseases Therapeutics Drugs Sales and Market Share by Type
8.4 India Liver Diseases Therapeutics Drugs Sales and Market Share by Application

9 Global Liver Diseases Therapeutics Drugs Manufacturers Analysis
9.1 F. Hoffmann-La Roche
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
9.1.2.1 Oral
9.1.2.2 Injection
9.1.3 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Gilead Sciences
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
9.2.2.1 Oral
9.2.2.2 Injection
9.2.3 Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 GlaxoSmithKline
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
9.3.2.1 Oral
9.3.2.2 Injection
9.3.3 GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 Johnson & Johnson
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
9.4.2.1 Oral
9.4.2.2 Injection
9.4.3 Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Merck
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
9.5.2.1 Oral
9.5.2.2 Injection
9.5.3 Merck Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Achillion Pharmaceuticals,
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
9.6.2.1 Oral
9.6.2.2 Injection
9.6.3 Achillion Pharmaceuticals, Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 AbbVie
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
9.7.2.1 Oral
9.7.2.2 Injection
9.7.3 AbbVie Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 Angion Biomedica
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
9.8.2.1 Oral
9.8.2.2 Injection
9.8.3 Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 Bayer
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
9.9.2.1 Oral
9.9.2.2 Injection
9.9.3 Bayer Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 LG Life Sciences
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Liver Diseases Therapeutics Drugs Product Type, Application and Specification
9.10.2.1 Oral
9.10.2.2 Injection
9.10.3 LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 Phenex Pharmaceuticals
9.12 ProMetic Life Sciences
9.13 Raptor Pharmaceuticals
9.14 Shenzhen Kangtai Biological Products
9.15 Verva Pharmaceuticals

10 Liver Diseases Therapeutics Drugs Maufacturing Cost Analysis
10.1 Liver Diseases Therapeutics Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Liver Diseases Therapeutics Drugs
10.3 Manufacturing Process Analysis of Liver Diseases Therapeutics Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Liver Diseases Therapeutics Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Liver Diseases Therapeutics Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Liver Diseases Therapeutics Drugs Market Forecast (2016-2021)
14.1 Global Liver Diseases Therapeutics Drugs Sales, Revenue and Price Forecast (2016-2021)
14.1.1 Global Liver Diseases Therapeutics Drugs Sales and Growth Rate Forecast (2016-2021)
14.1.2 Global Liver Diseases Therapeutics Drugs Revenue and Growth Rate Forecast (2016-2021)
14.1.3 Global Liver Diseases Therapeutics Drugs Price and Trend Forecast (2016-2021)
14.2 Global Liver Diseases Therapeutics Drugs Sales, Revenue and Growth Rate Forecast by Regions (2016-2021)
14.2.1 United States Liver Diseases Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
14.2.2 China Liver Diseases Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
14.2.3 Europe Liver Diseases Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
14.2.4 Japan Liver Diseases Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
14.2.5 Southeast Asia Liver Diseases Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
14.2.6 India Liver Diseases Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2016-2021)
14.3 Global Liver Diseases Therapeutics Drugs Sales, Revenue and Price Forecast by Type (2016-2021)
14.4 Global Liver Diseases Therapeutics Drugs Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Liver Diseases Therapeutics Drugs
Table Classification of Liver Diseases Therapeutics Drugs
Figure Global Sales Market Share of Liver Diseases Therapeutics Drugs by Type in 2015
Figure Oral Picture
Figure Injection Picture
Table Applications of Liver Diseases Therapeutics Drugs
Figure Global Sales Market Share of Liver Diseases Therapeutics Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2021)
Figure China Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2021)
Figure India Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2021)
Figure Global Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2021)
Figure Global Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2021)
Table Global Liver Diseases Therapeutics Drugs Sales of Key Manufacturers (2011-2016)
Table Global Liver Diseases Therapeutics Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Liver Diseases Therapeutics Drugs Sales Share by Manufacturers
Figure 2016 Liver Diseases Therapeutics Drugs Sales Share by Manufacturers
Table Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers (2011-2016)
Table Global Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers
Table 2016 Global Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers
Table Global Liver Diseases Therapeutics Drugs Sales and Market Share by Type (2011-2016)
Table Global Liver Diseases Therapeutics Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Liver Diseases Therapeutics Drugs by Type (2011-2016)
Figure Global Liver Diseases Therapeutics Drugs Sales Growth Rate by Type (2011-2016)
Table Global Liver Diseases Therapeutics Drugs Revenue and Market Share by Type (2011-2016)
Table Global Liver Diseases Therapeutics Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Liver Diseases Therapeutics Drugs by Type (2011-2016)
Figure Global Liver Diseases Therapeutics Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Liver Diseases Therapeutics Drugs Sales and Market Share by Regions (2011-2016)
Table Global Liver Diseases Therapeutics Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Liver Diseases Therapeutics Drugs by Regions (2011-2016)
Figure Global Liver Diseases Therapeutics Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Liver Diseases Therapeutics Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Liver Diseases Therapeutics Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Liver Diseases Therapeutics Drugs by Regions (2011-2016)
Figure Global Liver Diseases Therapeutics Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Liver Diseases Therapeutics Drugs Sales and Market Share by Application (2011-2016)
Table Global Liver Diseases Therapeutics Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Liver Diseases Therapeutics Drugs by Application (2011-2016)
Figure Global Liver Diseases Therapeutics Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
Figure United States Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
Figure United States Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Sales by Manufacturers (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Market Share by Manufacturers (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Sales by Type (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Market Share by Type (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Sales by Application (2011-2016)
Table United States Liver Diseases Therapeutics Drugs Market Share by Application (2011-2016)
Figure China Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
Figure China Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
Figure China Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
Table China Liver Diseases Therapeutics Drugs Sales by Manufacturers (2011-2016)
Table China Liver Diseases Therapeutics Drugs Market Share by Manufacturers (2011-2016)
Table China Liver Diseases Therapeutics Drugs Sales by Type (2011-2016)
Table China Liver Diseases Therapeutics Drugs Market Share by Type (2011-2016)
Table China Liver Diseases Therapeutics Drugs Sales by Application (2011-2016)
Table China Liver Diseases Therapeutics Drugs Market Share by Application (2011-2016)
Figure Europe Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
Figure Europe Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
Table Europe Liver Diseases Therapeutics Drugs Sales by Manufacturers (2011-2016)
Table Europe Liver Diseases Therapeutics Drugs Market Share by Manufacturers (2011-2016)
Table Europe Liver Diseases Therapeutics Drugs Sales by Type (2011-2016)
Table Europe Liver Diseases Therapeutics Drugs Market Share by Type (2011-2016)
Table Europe Liver Diseases Therapeutics Drugs Sales by Application (2011-2016)
Table Europe Liver Diseases Therapeutics Drugs Market Share by Application (2011-2016)
Figure Japan Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
Figure Japan Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
Table Japan Liver Diseases Therapeutics Drugs Sales by Manufacturers (2011-2016)
Table Japan Liver Diseases Therapeutics Drugs Market Share by Manufacturers (2011-2016)
Table Japan Liver Diseases Therapeutics Drugs Sales by Type (2011-2016)
Table Japan Liver Diseases Therapeutics Drugs Market Share by Type (2011-2016)
Table Japan Liver Diseases Therapeutics Drugs Sales by Application (2011-2016)
Table Japan Liver Diseases Therapeutics Drugs Market Share by Application (2011-2016)
Figure Southeast Asia Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
Figure Southeast Asia Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
Table Southeast Asia Liver Diseases Therapeutics Drugs Sales by Manufacturers (2011-2016)
Table Southeast Asia Liver Diseases Therapeutics Drugs Market Share by Manufacturers (2011-2016)
Table Southeast Asia Liver Diseases Therapeutics Drugs Sales by Type (2011-2016)
Table Southeast Asia Liver Diseases Therapeutics Drugs Market Share by Type (2011-2016)
Table Southeast Asia Liver Diseases Therapeutics Drugs Sales by Application (2011-2016)
Table Southeast Asia Liver Diseases Therapeutics Drugs Market Share by Application (2011-2016)
Figure India Liver Diseases Therapeutics Drugs Sales and Growth Rate (2011-2016)
Figure India Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2011-2016)
Figure India Liver Diseases Therapeutics Drugs Sales Price Trend (2011-2016)
Table India Liver Diseases Therapeutics Drugs Sales by Manufacturers (2011-2016)
Table India Liver Diseases Therapeutics Drugs Market Share by Manufacturers (2011-2016)
Table India Liver Diseases Therapeutics Drugs Sales by Type (2011-2016)
Table India Liver Diseases Therapeutics Drugs Market Share by Type (2011-2016)
Table India Liver Diseases Therapeutics Drugs Sales by Application (2011-2016)
Table India Liver Diseases Therapeutics Drugs Market Share by Application (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Global Market Share (2011-2016)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Gilead Sciences Liver Diseases Therapeutics Drugs Global Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Liver Diseases Therapeutics Drugs Global Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Liver Diseases Therapeutics Drugs Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Liver Diseases Therapeutics Drugs Global Market Share (2011-2016)
Table Achillion Pharmaceuticals, Basic Information List
Table Achillion Pharmaceuticals, Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Achillion Pharmaceuticals, Liver Diseases Therapeutics Drugs Global Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AbbVie Liver Diseases Therapeutics Drugs Global Market Share (2011-2016)
Table Angion Biomedica Basic Information List
Table Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Angion Biomedica Liver Diseases Therapeutics Drugs Global Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Liver Diseases Therapeutics Drugs Global Market Share (2011-2016)
Table LG Life Sciences Basic Information List
Table LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure LG Life Sciences Liver Diseases Therapeutics Drugs Global Market Share (2011-2016)
Table Phenex Pharmaceuticals Basic Information List
Table ProMetic Life Sciences Basic Information List
Table Raptor Pharmaceuticals Basic Information List
Table Shenzhen Kangtai Biological Products Basic Information List
Table Verva Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liver Diseases Therapeutics Drugs
Figure Manufacturing Process Analysis of Liver Diseases Therapeutics Drugs
Figure Liver Diseases Therapeutics Drugs Industrial Chain Analysis
Table Raw Materials Sources of Liver Diseases Therapeutics Drugs Major Manufacturers in 2015
Table Major Buyers of Liver Diseases Therapeutics Drugs
Table Distributors/Traders List
Figure Global Liver Diseases Therapeutics Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Liver Diseases Therapeutics Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Liver Diseases Therapeutics Drugs Sales Forecast by Regions (2016-2021)
Table Global Liver Diseases Therapeutics Drugs Sales Forecast by Type (2016-2021)
Table Global Liver Diseases Therapeutics Drugs Sales Forecast by Application (2016-2021)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の肝臓病治療薬市場:販売動向2017] (Global Liver Diseases Therapeutics Drugs Sales Market Report 2017 / QYR70323058)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆